Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Vaishali Pharma Ltd.
Swot
Vaishali Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Vaishali Pharma Ltd. has 14 Strengths, 9 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(9)
Opportunity
(0)
Threats
(0)
Others
(4)
Positive Breakout Second Resistance ( LTP > R2)
Relative Outperformance versus Industry over 1 Month
Expensive Performers (DVM)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
High Volume, High Gain
Top Gainers
High Volume, High Gain
Volume Shockers
PE higher than Industry PE
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Major fall in TTM Net Profit
Increasing Trend in Non-Core Income
Stocks Underperforming their Industry Price Change in the Quarter
Expensive Performers (DVM)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
